Dubbed the Pediatric Exclusivity Provision, the licensing position has led to a lot more than 150 drugs now being qualified for specific use in children. But with an increasing amount of pediatric trials getting conducted in countries where in fact the resulting medicines often aren’t even available, the provision is said by some critics pads the pockets of ‘big pharma’ more than it benefits youngsters. Image by woodleywonderworks via Flickr Innovative Commons.. By Monica Heger Although kids suffer from most of the same diseases as adults and so are frequently treated with the same drugs, only a small fraction of approved medicines is ever tested in pediatric clinical trials. To encourage even more safety and efficacy studies of drugs in kids, in 1997 the united states Food and Medication Administration produced a particular provision that grants six-month patent extensions to medications screened in children.You will see the entire Kaiser Daily Health Plan Survey, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, debates and discussions. The Kaiser Daily Wellness Policy Report is published for Kaisernetwork.org, a free support of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Plank Kaiser and Company Family Foundation. All rights reserved.. Cognitive fluctuations much more likely to occur in old persons with Alzheimer’s disease Cognitive fluctuations, or episodes when train of thought temporarily is lost, will occur in older persons who are developing Alzheimer’s disease than in their healthy peers, in accordance to scientists at Washington University School of Medicine in St.